Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Terry Doyle
Institution:
Vion Pharmaceuticals (United States)
Observed institution:
Vion Pharmaceuticals (United States)
OpenAlex ID:
A5039895409
Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
2003
·
John Murren
, Manuel Modiano
, et al.
·
PubMed
·
108
Show more works
View as search
Works count:
1
Citation count:
108
H-index:
1
I10-index:
1
Year
Topic
Type
